Axa S.A. Organon & Co. Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Organon & Co. stock. As of the latest transaction made, Axa S.A. holds 240,665 shares of OGN stock, worth $3.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

240,665

Previous 310,500 22.49%

Holding current value

$3.95 Million

Previous $6.43 Million 28.38%

% of portfolio

0.01%

Previous 0.02%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$18.65 - $23.03 $1.3 Million - $1.61 Million	-69,835 Reduced 22.49%	240,665 $4.6 Million
Q2 2024 Aug 14, 2024	SELL	$17.45 - $21.96 $861,436 - $1.08 Million	-49,366 Reduced 13.72%	310,500 $6.43 Million
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $636,167 - $867,920	46,166 Added 14.72%	359,866 $6.77 Million
Q4 2023 Jul 16, 2024	SELL	$10.95 - $17.32 $505,517 - $799,595	-46,166 Reduced 12.83%	313,700 $4.52 Million
Q4 2023 Feb 14, 2024	SELL	$10.95 - $17.32 $4.67 Million - $7.39 Million	-426,500 Reduced 57.62%	313,700 $4.52 Million
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $1.27 Million - $1.81 Million	76,302 Added 11.49%	740,200 $12.8 Million
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $3.58 Million - $4.57 Million	185,720 Added 38.84%	663,898 $13.8 Million
Q1 2023 May 15, 2023	BUY	$21.42 - $32.08 $42,368 - $63,454	1,978 Added 0.42%	478,178 $11.2 Million
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $11.1 Million - $13.6 Million	476,200 New	476,200 $13.3 Million

Others Institutions Holding OGN

# of Institutions

790

Shares Held

201M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account